Nasdaq Pnt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq pnt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pnt Today - Breaking & Trending Today

POINT Biopharma Global Inc. (NASDAQ:PNT) Receives Consensus Rating of "Hold" from Analysts

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) has been given a consensus recommendation of “Hold” by the ten research firms that are currently covering the stock, Marketbeat.com reports. Ten research analysts have rated the stock with a hold rating. The average 12-month target price among brokerages that have updated their coverage on the […] ....

United States , Piper Sandler , Leerink Partnrs , William Blair , Proshare Advisors , Group Plc , American International Group Inc , Biopharma Global Inc , Fund Management Co , Point Biopharma Global Inc , Get Free Report , Retirement System , Fund Management , General Group Plc , Share Advisors , American International Group , International Group , Get Free , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global Inc. (NASDAQ:PNT) Receives Average Recommendation of "Hold" from Brokerages

Shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) have received a consensus rating of “Hold” from the ten analysts that are covering the firm, MarketBeat Ratings reports. Ten analysts have rated the stock with a hold recommendation. The average 12 month price objective among analysts that have updated their coverage on the […] ....

Raymond James , Geode Capital Management , Biopharma Global Company Profile , Vanguard Group Inc , Blackrock Inc , Biopharma Global Inc , Get Free Report , Marketbeat Ratings , Capital Management , Street Corp , Track Capital , Global Company , Get Free , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

Brookline Capital Management Reaffirms Hold Rating for POINT Biopharma Global (NASDAQ:PNT)

Brookline Capital Management reaffirmed their hold rating on shares of POINT Biopharma Global (NASDAQ:PNT – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $12.50 price target on the stock, down from their prior price target of $27.00. Other equities research analysts also recently issued reports about the […] ....

United States , Piper Sandler , William Blair , Raymond James , Jefferies Financial Group , Bellevue Group , Allspring Global Investments Holdings , American International Group Inc , Thrivent Financial For Lutherans , Biopharma Global Company Profile , Biopharma Global Inc , Brookline Capital Management , Free Report , Financial Group , Get Free Report , Global Investments Holdings , American International Group , International Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt , Reiterated Rating ,

POINT Biopharma Global (NASDAQ:PNT) Shares Gap Down to $14.02

Shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $14.02, but opened at $12.46. POINT Biopharma Global shares last traded at $12.45, with a volume of 4,168,836 shares. Wall Street Analyst Weigh In Several equities analysts recently issued […] ....

Leerink Partnrs , Raymond James , William Blair , Swiss National Bank , Jefferies Financial Group , Citigroup Inc , Biopharma Global Inc , Cibc World Market Inc , Vanguard Group Inc , Get Free Report , Financial Group , Global Price , National Bank , Montreal Can , World Market , Vanguard Group , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

7,174 Shares in POINT Biopharma Global Inc. (NASDAQ:PNT) Purchased by Beutel Goodman & Co Ltd.

Beutel Goodman & Co Ltd. purchased a new position in shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 7,174 shares of the company’s stock, valued at approximately $64,000. A number of […] ....

Piper Sandler , William Blair , Biopharma Global Inc , Securities Exchange Commission , Cibc World Market Inc , Swiss National Bank , Vanguard Group Inc , Biopharma Global Company Profile , Beutel Goodman Co Ltd , Citigroup Inc , Beutel Goodman , Free Report , National Bank , Montreal Can , World Market , Vanguard Group , Global Stock , Get Free Report , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,